4 years ago

Cambridge-based Qureight Secures £1.5 Million Seed Funding

  • Qureight, a Cambridge, UK-based data company focusing on complex diseases, has raised £1.5 million in seed funding led by Playfair Capital, with participation from Life Sciences funds Meltwind, Ascension, and Cambridge Angels

  • Qureight uses cloud-based technology to assist in the structuring of image and paired clinical metadata in complex diseases, enabling the development of AI-based tools for understanding diseases like lung fibrosis, complex cancers, and COVID-19

  • The company plans to use the funding to expand operations and business reach.

      • ProblemLife Sciences

      "making sense of large amounts of image and clinical data in diseases such as lung fibrosis, complex cancers, and COVID-19"

      Solution

      "using cloud-based technology to structure this data, allowing for the development of AI-based tools to understand these diseases"

      Covered on